Cellular and subcellular localization of CXCL12 and CXCR4 in rat nociceptive structures: physiological relevance.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 22694179)

Published in Eur J Neurosci on June 14, 2012

Authors

Annabelle Reaux-Le Goazigo1, Cyril Rivat, Patrick Kitabgi, Michel Pohl, Stéphane Melik Parsadaniantz

Author Affiliations

1: Centre de recherche de l'Institut Cerveau Moelle (CrICM), UMR S 975 INSERM-UMR 7225 CNRS-UPMC, Université Pierre et Marie Curie, Faculty of Medicine Pitié Salpêtrière, 91 Boulevard de l'Hôpital, 75013 Paris, France. annabelle.reaux@inserm.fr

Articles citing this

CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord. J Neuroinflammation (2014) 0.96

SDF1-CXCR4 signaling contributes to persistent pain and hypersensitivity via regulating excitability of primary nociceptive neurons: involvement of ERK-dependent Nav1.8 up-regulation. J Neuroinflammation (2015) 0.89

CXCL12 chemokine and GABA neurotransmitter systems crosstalk and their putative roles. Front Cell Neurosci (2014) 0.86

Opioid-induced central immune signaling: implications for opioid analgesia. Headache (2015) 0.79

Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain. Mol Pain (2016) 0.77

Central administration of C-X-C chemokine receptor type 4 antagonist alleviates the development and maintenance of peripheral neuropathic pain in mice. PLoS One (2014) 0.76

Up-regulation of CXCR4 expression contributes to persistent abdominal pain in rats with chronic pancreatitis. Mol Pain (2017) 0.75

Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease. J Neuroinflammation (2016) 0.75

The role of some chemokines from the CXC subfamily in a mouse model of diabetic neuropathy. J Diabetes Res (2015) 0.75

Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells. Proc Natl Acad Sci U S A (2016) 0.75

[EXPRESS] CXCL12/CXCR4 signaling mediated ERK1/2 activation in spinal cord contributes to the pathogenesis of postsurgical pain in rats. Mol Pain (2017) 0.75

SDF1-CXCR4 Signaling Maintains Central Post-Stroke Pain through Mediation of Glial-Neuronal Interactions. Front Mol Neurosci (2017) 0.75

CXCR4 antagonist AMD3100 elicits analgesic effect and restores the GlyRα3 expression against neuropathic pain. J Pain Res (2017) 0.75

Articles by these authors

A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci (2002) 2.71

Chemokines: a new class of neuromodulator? Nat Rev Neurosci (2007) 1.76

Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci (2002) 1.52

Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem (2008) 1.37

Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol (2005) 1.32

Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia. Pain (2010) 1.32

Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci (2011) 1.31

Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J Comp Neurol (2005) 1.30

Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci (2003) 1.30

JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J Neurochem (2008) 1.27

The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J Cell Sci (2005) 1.26

Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem (2005) 1.26

The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg (2002) 1.22

Opioid-induced hyperalgesia: abnormal or normal pain? Neuroreport (2003) 1.21

SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. J Neurosci (2010) 1.18

CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J Neurosci (2011) 1.17

Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons. Mol Ther (2005) 1.14

Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. Proc Natl Acad Sci U S A (2010) 1.09

Altered processing of the neurotensin/neuromedin N precursor in PC2 knock down mice: a biochemical and immunohistochemical study. J Neurochem (2002) 1.08

Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. Mol Ther (2007) 1.04

Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: behavioral and biochemical studies. J Neurosci (2005) 1.03

Differential implication of proinflammatory cytokine interleukin-6 in the development of cephalic versus extracephalic neuropathic pain in rats. J Neurosci (2008) 1.00

Constitutive activation of the neurotensin receptor 1 by mutation of Phe(358) in Helix seven. Br J Pharmacol (2002) 0.99

The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc Natl Acad Sci U S A (2006) 0.97

Ketamine improves the management of exaggerated postoperative pain observed in perioperative fentanyl-treated rats. Anesthesiology (2005) 0.95

Chemokines and brain functions. Curr Drug Targets Inflamm Allergy (2005) 0.94

Target-controlled dosing of remifentanil during cardiac surgery reduces postoperative hyperalgesia. J Cardiothorac Vasc Anesth (2011) 0.94

Lentiviral-mediated targeted transgene expression in dorsal spinal cord glia: tool for the study of glial cell implication in mechanisms underlying chronic pain development. J Neurosci Methods (2007) 0.92

Stress-induced hyperalgesia: any clinical relevance for the anesthesiologist? Anesthesiology (2011) 0.86

Dendrite-selective redistribution of the chemokine receptor CXCR4 following agonist stimulation. Mol Cell Neurosci (2006) 0.84

NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9. J Neuroinflammation (2012) 0.84

Antinociceptive effect of peripheral serotonin 5-HT2B receptor activation on neuropathic pain. Pain (2012) 0.83

Nitrous oxide revisited: evidence for potent antihyperalgesic properties. Anesthesiology (2005) 0.82

Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats. Can J Anaesth (2008) 0.80

Effects of nefopam on early postoperative hyperalgesia after cardiac surgery. J Cardiothorac Vasc Anesth (2012) 0.80

The Arg617-Arg618 cleavage site in the C-terminal domain of PC1 plays a major role in the processing and targeting of the enzyme within the regulated secretory pathway. J Neurochem (2003) 0.79

Production of recombinant large proneurotensin/neuromedin N-derived peptides and characterization of their binding and biological activity. Biochem Biophys Res Commun (2002) 0.79

[Chemokines as new actors in the dopaminergic system]. Biol Aujourdhui (2011) 0.79

Tolerance and opioid-induced hyperalgesia. Is a divorce imminent? Pain (2012) 0.78

Implication of CCR2 chemokine receptor in cocaine-induced sensitization. J Mol Neurosci (2011) 0.77

Insertion of dibasic residues directs a constitutive protein to the regulated secretory pathway. Biochem Biophys Res Commun (2002) 0.77

Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cell-derived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats. Endocrinology (2007) 0.77

Pulsed radiofrequency enhances morphine analgesia in neuropathic rats. Neuroreport (2012) 0.76

Sciatic nerve block fails in preventing the development of late stress-induced hyperalgesia when high-dose fentanyl is administered perioperatively in rats. Reg Anesth Pain Med (2012) 0.76

Gene-based approaches in pain research and exploration of new therapeutic targets and strategies. Eur J Pharmacol (2013) 0.76

Early alterations of Hedgehog signaling pathway in vascular endothelial cells after peripheral nerve injury elicit blood-nerve barrier disruption, nerve inflammation, and neuropathic pain development. Pain (2016) 0.76

Gene-based approaches in the study of pathological pain. Methods Mol Biol (2010) 0.75

Perioperative or postoperative nerve block for preventive analgesia: should we care about the timing of our regional anesthesia? Anesth Analg (2013) 0.75

The effects of low-dose ketamine on the analgesia nociception index (ANI) measured with the novel PhysioDoloris™ analgesia monitor: a pilot study. J Clin Monit Comput (2014) 0.75

[From inflammation to pain: experimental gene therapy]. Med Sci (Paris) (2004) 0.75